At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Berlin based CFO’ operating in the Biotechnology space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Richard Stoffelen
Chief Financial Officer of Centogene
Richard serves as CFO, providing international expertise in global financial topics at CENTOGENE. His experience and know-how supports CENTOGENE in its continued global growth plans. With over 25 years of experience in international leadership roles covering the full width of governance and risk concepts, his expertise, combined with his extensive change management skills, ensures the finance organization will enable the company to continue its expansive growth path. Richard previously served as Head of Internal Audit at Holcim, a listed multinational company in Switzerland, where he was asked to lead the change of this function from a globally distributed model to a centralized, risk based, model. From 1985 to 2013 he was active in different Audit- and Management-positions at (a.o.) KPMG, in Chicago, Frankfurt, Hong Kong and the Netherlands. During his international audit tenure, Richard was responsible for audits of a multitude of small and large (listed on various stock exchanges, including the US) clients in a wide variety of industries, including the Pharma industry. He developed a new entity on strategic alliances, where he also provided strategy consulting services, including business planning and related funding. As Partner in Charge of one of the offices, he created values-based turn-around. Subsequently, he was HR responsible in the management team for the audit practice of KPMG NL-south. This role led to a further roll out of his management development initiatives in Hong Kong, China and Germany. Furthermore, Richard was involved in IPO`s and Bond issuances on a variety of stock exchanges. He was an active public speaker during his leadership and business development regarding the role of the China Practice, both in Hong Kong-China, and in Europe – where he led the EMA China Practice. Richard graduated as a Dutch CPA with the NBA and Tilburg University – the Netherlands, with further executive education programs at Harvard Business School, Insead (Executive MBA), IMD and IESE.
Follow Richard Stoffelen:
About Centogene: CENTOGENE provides methods and technology for human genetics analysis.
Thomas Dürre
Chief Financial Officer of Isotopen Technologien München
Thomas accepted the position as Chief Financial Officer at ITM Isotopen Technologien München AG in April 2016. Before that he worked for 3 years as Senior Vice President at Software AG and was responsible for all aspects of Global Integration Management. Prior to this he was CFO at alfabet AG for 15 years and headed the successful sale and merger of alfabet AG to Software AG. Thomas started his career in 1991 at Ernst & Young and worked from 1996 until 1998 as Controller Germany for the US based international waste management company BFI. Thomas has 25 years of work experience in finance, especially in the international expansion and growth of start-ups and preparation as well as execution of exit strategies in private equity companies. He holds a Masters Degree in Business Administration (Dipl.-Kfm.) from the University of Cologne (Germany).
Follow Thomas Dürre:
About Isotopen Technologien München: Isotopen Technologien München is a privately held biotechnology and radiopharmaceutical group of companies.
Martin Reichhuber
Chief Financial Officer of 4TEEN4 Pharmaceuticals
Follow Martin Reichhuber:
About 4TEEN4 Pharmaceuticals: 4TEEN4 Pharmaceuticals develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions.
Gerrit Maass
CFO of Pantherna Therapeutics
Follow Gerrit Maass:
About Pantherna Therapeutics: Pantherna Therapeutics is a privately-held biopharmaceutical company.
Gerrit Maass
CFO of Pantherna Therapeutics
Follow Gerrit Maass:
About Pantherna Therapeutics: Pantherna Therapeutics is a privately-held biopharmaceutical company.